Given that HDAC6 regulates microtubule dynamics through deacetylation and that vincristine, a cornerstone ALL chemotherapeutic, targets microtubules, we hypothesized that WT161 might synergize with vincristine by modulating microtubule stability. Here, HDAC6 is linked to acute lymphoblastic leukemia.